Search Results - Endovascular Today

evt | Article | June 2016 Supplement

Achieving Durable Outcomes in Dialysis Access With the GORE® VIABAHN® Endoprosthesis

Leading physicians share best practices and discuss how the GORE VIABAHN Endoprosthesis has contributed to their practices.

With Alejandro Alvarez, MD; Daniel Patel, MD; John R. Ross, MD; and Peter Wayne, MD

evt | Article | June 2017 Supplement

Case Report: Endovascular Salvage of an Abandoned AV Graft

Restoring and maintaining access patency using the GORE® VIABAHN® Endoprosthesis.

By Daniel V. Patel, MD

evt | Article | June 2018 Supplement

Undersizing to the Outflow Vein

Technique and considerations in deployment of the GORE® VIABAHN® Endoprosthesis at the venous anastomosis of dialysis access arteriovenous grafts.

By Daniel V. Patel, MD, FASDIN

evt | Article | October 2015

A New Era in Embolic Devices

Novel uses for detachable coils and microvascular plugs and how they are put into practice in the real world.

By Bulent Arslan, MD; Frank Hao, MD; Daniel Powell, MD; Vladimir Sheynzon, MD; John J. Park, MD, PhD; Jinha M. Park, MD, PhD; and Jason W. Mitchell, MD, MPH, MBA

evt | Article | April 2023

Frame, Anchor, Pack: Simplifying Complex Cases With Penumbra’s Embolization Platform

With Andrew J. Gunn, MD; Tarik Babar, BS; Naiem Nassiri, MD, FSVS, RPVI; Amit J. Dwivedi, MD, FACS; Gerald A. Cheadle, MD; Robert Evans Heithaus, MD; Daniel K. Han, MD; Saadat Shariff, MD; and Neil Patel, MD

evt | Article | March 2025

EVAR Pearls, Pitfalls, and New Possibilities

By Javairiah Fatima, MD, FACS, DFSVS

evt | Article | February 2018

Adding Efficiency to Effectiveness

By Blaise Baxter, MD

Sponsored by Boston Scientific Corporation

evt | Article | May 2021

The Changing Landscape of Medical Education: Making Online Learning Personal and Effective

Breaking the mold to provide customized curricula on demand to improve patient care.

By Michael R. Jaff, DO, FACP, FACC

evt | Article | August 2017

Real-World Decision Making

By John A. Kaufman, MD

evt | Article | August 2017

Practical IR Approach to Early Stage Hepatocellular Carcinoma

Moderator: Robert J. Lewandowski, MD, FSIR
Panel: Daniel B. Brown, MD, FSIR; Riad Salem, MD, MBA, FSIR; and Fred T. Lee Jr, MD

evt | Article | September 2006

Guidelines for the Use of Optional (Retrievable and Convertible) Vena Cava Filters

A summary of the SIR multidisciplinary consensus statement.

By John A. Kaufman, MD

evt | Article | August 2018

Transatlantic Perspectives on Vessel Preparation

Interventional experts from the United States and Europe discuss the current state of vessel prep and their experience with the FLEX Dynamic Scoring Catheter®.

Moderator: Richard Kovach, MD
Panel: Thomas Zeller, MD; Daniel Hayoz, MD; Miguel Montero-Baker, MD; and Nicolas Mouawad, MD

evt | Article | January 2023

Panel Discussion: Perspectives on Applying BEST-CLI in Practice

Experts discuss the study’s findings, its strengths and limitations, and clinical implications, as well as lessons learned regarding optimal medical therapy and what needs to be explored further.

With Daniel Clair, MD; Sanjay Misra, MD; Leigh Ann O'Banion, MD; and Mehdi H. Shishehbor, DO, MPH, PhD

evt | Article | September 2021

Panel Discussion: CFA Disease: Exploring Options in a Typically Surgical Indication

Moderator Peter A. Schneider, MD, asks Daniela Branzan, MD; Daniel Clair, MD; Tony Das, MD, FACC; and Yann Gouëffic, MD, PhD, about their approaches to CFA lesions, patient and clinical factors they consider, data that support an endovascular approach, preferred tools and rules of thumb, and how treatment of CFA disease looks in the future.

evt | News | June 19, 2019

FDA Paclitaxel Advisory Meeting Day 1: Panel Addresses Updated Data, Signal Presence, Class Effect, Missing Data, Subgroups, and Causes of Death

June 19, 2019—Among efforts to explore and address concerns raised by recent meta-analysis data that found an increased mortality signal in patients treated with lower extremity paclitaxel delivery devices, the US Food & Drug Administration convened an advisory committee to be held June 19–20, 2019, in Gaithersburg, Maryland.

evt | News | June 19, 2019

FDA Advisory Meeting Day 2: Panel Weighs the Future of Paclitaxel and Clinical Trials in PAD

June 20, 2019—After a full first day of presentations, questions, deliberations, and recommendations, US FDA advisors reconvened to address additional queries posed by the agency as to the safety and efficacy of paclitaxel therapies in peripheral artery disease (PAD), as well as future steps needed to ensure and communicate their status.

evt | Article | March 2018

Abdominal Aortic Approaches

By Daniel G. Clair, MD, and Timothy A. Resch, MD, PhD

evt | Article | September 2020

Roundtable Discussion: Paclitaxel in PAD: Where We Stand

A panel discussion on the current state of paclitaxel in peripheral artery disease, including how device use has changed, conversations with patients about safety and informed consent, key lessons learned, and how to move forward.

With Daniel J. Bertges, MD; Theodosios Bisdas, MD; Bruce H. Gray, DO, FSCAI, MSVM; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; and Sabine Steiner, MD; with additional commentary by Jos C. van den Berg, MD, PhD

evt | Article | May 2021

LimFlow Percutaneous Deep Venous Arterialization

Trial data updates and experiences with latest-generation techniques and technologies.

With Daniel Clair, MD; Mehdi H. Shishehbor, DO, MPH, PhD; Jorge Martínez Trabal, MD, FACS, RPVI; Michiel Schreve, MD; Miguel Montero-Baker, MD; Brian Lepow, DPM; and Roberto Ferraresi, MD

evt | Article | February 2021

RAPID Pathways’ Approach to an Urgent Safety Signal

Discussing the challenges, opportunities, and lessons learned from paclitaxel in PAD.

By Daniel J. Bertges, MD; Mitchell W. Krucoff, MD; Aaron Lottes, PhD, MBA; Misti Malone, PhD; George Papandreou, PhD; Sara Royce, PhD; and Eleni Whatley, PhD